The key advantage of our technology is its efficacy. Already after the first round of recombination, our technology generates high-quality libraries of mosaic genes or genomes, consisting only of true recombinants. A high proportion of novel enzymes created with this technology are functional, because crossovers only occur at sequence-defined domains.

Moreover, no frame-shifts, stop codons, insertions or deletions are generated, leaving the integrity of the resultant 3D-structures undisturbed.

The resulting recombinants are then screened to identify genes encoding enzymes with novel or improved functions.

To learn more about the performance characteristics and the advantages provided by EUCODIS Bioscience's technology, please contact Dr. Henryk Kalisz, CSO.